Clinical trial · people

NMN: single oral doses up to 500 mg were safe in 10 healthy men

Checked against the paper Clinical trialPublished by PepVault

The takeaway

This early human study found single oral NMN doses of 100 to 500 mg caused no significant problems over 5 hours in healthy men and were broken down by the body, but it does not cover long-term use.

Kind
Clinical trial
Studied in
People
Number studied
10
Published
2020
Journal
Endocr J

What they tested

The team wanted to know whether a single oral dose of NMN is safe in healthy men and how the body breaks it down.

How the study was done

A single-arm, non-randomized trial with no comparison group, in 10 healthy Japanese men who each took single oral doses of 100, 250 and 500 mg of NMN. Each dose was followed by 5 hours of checks and blood sampling, with eye exams and a sleep quality score done before and after.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking NMN? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

None of the NMN doses led to significant symptoms, and heart rate, blood pressure, oxygen saturation and body temperature did not change significantly. In blood tests, serum bilirubin went up and serum creatinine, chloride and blood glucose went down, but all stayed within normal ranges and the shifts did not depend on the dose. Eye exam results and sleep quality scores were the same before and after. Blood levels of two NMN breakdown products, N-methyl-2-pyridone-5-carboxamide and N-methyl-4-pyridone-5-carboxamide, rose significantly, and more so at higher doses.

What it doesn’t show

This was a very small trial in healthy men only, with no placebo group and no randomization. It looked at single doses over a few hours, so it says nothing about taking NMN daily or for weeks, and it did not test any health or aging benefit.

The paper

Irie et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. 2020.

The compound

More studies on NMN

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking NMN? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo